Literature DB >> 7871015

Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys.

R D Spealman1.   

Abstract

Modification of the behavioral effects of cocaine by the selective serotonin (5-HT) uptake inhibitors citalopram and fluoxetine and the selective dopamine (DA) uptake inhibitor GBR 12909 was investigated in squirrel monkeys trained under a fixed-interval schedule of reinforcement or a two-lever cocaine-discrimination procedure. Under the fixed-interval schedule cocaine (0.03-1.78 mg/kg) produced dose-related increases in response rate, reaching an average maximum of 215% of control after a dose of 0.3 mg/kg. Similar rate-increasing effects were seen with GBR 12909 (3.0 or 10.0 mg/kg), but not citalopram (10.0 or 17.8 mg/kg) or fluoxetine (10.0 mg/kg). Pretreatment with citalopram or fluoxetine attenuated the rate-increasing effects of cocaine and produced an overall downward shift in the cocaine dose-response function. Pretreatment with GBR 12909, on the other hand, produced an overall leftward shift in the cocaine dose-response function. Under the drug-discrimination procedure cocaine (0.03-1.78 mg/kg) engendered dose-related increases in the percentage of cocaine-appropriate responses, as did GBR 12909 (1.0-17.8 mg/kg) but not citalopram (1.0-17.8 mg/kg). Pretreatment with citalopram attenuated the discriminative stimulus effects of cocaine and produced an overall rightward shift in the cocaine dose-response function, whereas pretreatment with GBR 12909 produced an overall leftward shift in the cocaine dose-response function. The results show that selective 5-HT and DA uptake inhibitors can modify the rate-altering and discriminative stimulus effects of cocaine in qualitatively different ways and suggest a modulatory role for 5-HT uptake inhibition in the behavioral effects of cocaine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7871015     DOI: 10.1007/bf02247368

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  43 in total

1.  Treatment of cocaine abuse with mazindol.

Authors:  P Berger; F Gawin; T R Kosten
Journal:  Lancet       Date:  1989-02-04       Impact factor: 79.321

2.  Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences.

Authors:  M G De Simoni; G Dal Toso; F Fodritto; A Sokola; S Algeri
Journal:  Brain Res       Date:  1987-05-12       Impact factor: 3.252

3.  Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan.

Authors:  M E Carroll; S T Lac; M Asencio; R Kragh
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior.

Authors:  M E Reith; B E Meisler; H Sershen; A Lajtha
Journal:  Biochem Pharmacol       Date:  1986-04-01       Impact factor: 5.858

5.  Evidence for perceptual masking of the discriminative morphine stimulus.

Authors:  D V Gauvin; A M Young
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935.

Authors:  M E Reith; G Selmeci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

7.  Serotonin--dopamine interactions in the nigrostriatal system.

Authors:  P C Waldmeier; A A Delini-Stula
Journal:  Eur J Pharmacol       Date:  1979-05-15       Impact factor: 4.432

8.  Behavioral aspects of serotonin-dopamine interaction in the monkey.

Authors:  S Korsgaard; J Gerlach; E Christensson
Journal:  Eur J Pharmacol       Date:  1985-12-03       Impact factor: 4.432

9.  Sodium-sensitive cocaine binding to rat striatal membrane: possible relationship to dopamine uptake sites.

Authors:  L T Kennedy; I Hanbauer
Journal:  J Neurochem       Date:  1983-07       Impact factor: 5.372

10.  A portion of [3H]cocaine binding in brain is associated with serotonergic neurons.

Authors:  M E Reith; H Sershen; D L Allen; A Lajtha
Journal:  Mol Pharmacol       Date:  1983-05       Impact factor: 4.436

View more
  26 in total

1.  Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys by direct and indirect activation of 5-HT2C receptors.

Authors:  Daniela Rüedi-Bettschen; Roger D Spealman; Donna M Platt
Journal:  Psychopharmacology (Berl)       Date:  2015-04-17       Impact factor: 4.530

2.  Serotonin1B receptor stimulation enhances cocaine reinforcement.

Authors:  L H Parsons; F Weiss; G F Koob
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

3.  Translocation of dopamine and binding of WIN 35,428 measured under identical conditions in cells expressing the cloned human dopamine transporter.

Authors:  M E Reith; C Xu; L Zhang; L L Coffey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

4.  Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.

Authors:  Neil E Paterson; Allison Fedolak; Berend Olivier; Taleen Hanania; Afshin Ghavami; Barbara Caldarone
Journal:  Pharmacol Biochem Behav       Date:  2010-03-25       Impact factor: 3.533

5.  Antinociceptive interactions between Mu-opioid receptor agonists and the serotonin uptake inhibitor clomipramine in rhesus monkeys: role of Mu agonist efficacy.

Authors:  Matthew L Banks; Kenner C Rice; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2010-07-30       Impact factor: 4.030

6.  Effects of drug history on the acquisition of responding maintained by GBR 12909 in rhesus monkeys.

Authors:  F H Wojnicki; J R Glowa
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

7.  Synthesis of 8-thiabicyclo[3.2.1]octanes and their binding affinity for the dopamine and serotonin transporters.

Authors:  Duy-Phong Pham-Huu; Jeffrey R Deschamps; Shanghao Liu; Bertha K Madras; Peter C Meltzer
Journal:  Bioorg Med Chem       Date:  2006-10-27       Impact factor: 3.641

8.  Differential effects of serotonin 5-HT1A receptor agonists on the discriminative stimulus effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rats and rhesus monkeys.

Authors:  Jun-Xu Li; Wouter Koek; Kenner C Rice; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2010-01-06       Impact factor: 4.030

9.  Behavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkey.

Authors:  Heather L Kimmel; Daniel F Manvich; Bruce E Blough; S Stevens Negus; Leonard L Howell
Journal:  Pharmacol Biochem Behav       Date:  2009-09-17       Impact factor: 3.533

Review 10.  Nonhuman primate neuroimaging and cocaine medication development.

Authors:  Leonard L Howell
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.